http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03006458-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_113c281c6cd4058c524fb7149bb35f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7641467e74b2b5e8fb2f4c28507f235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c95a910ede3bac72cfebc77294afdbd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49a287a65252d5f849bdd6f67db9145c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
filingDate 2002-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ce91040250adf1f569eb509d850d8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045ba2c5c9e2809addbfabbfaad11d68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d74b4442db626658493843f8d3782b7
publicationDate 2003-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03006458-A1
titleOfInvention Benzo [g] quinoline derivatives for treating glaucoma and myopia
abstract The invention provides a compound of formula I wherein A, B, X, Y and R1 are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceutical agents for the treatment of glaucoma and myopia.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007504198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1859802-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707476-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005023258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168056-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1859802-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130775-B2
priorityDate 2001-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9703054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0512952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9801444-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0659430-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129122456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127645893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226567204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236070653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21903993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70451296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229027386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239490608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5150145

Total number of triples: 58.